Case Reports
[Sedural toxicity]
[Article in
Hebrew]
Affiliations
- PMID: 1879765
Item in Clipboard
Case Reports
[Sedural toxicity]
[Article in
Hebrew]
Harefuah.
.
Abstract
Phenazopyridine (Sedural) is widely used in the treatment of dysuria. It is considered a benign drug and most physicians are unaware of its potential toxicity. A 24-year-old woman who developed methemoglobinemia, acute renal failure and hemolytic anemia following a single 1 g dose of the drug is presented.
Similar articles
-
Acute methemoglobinemia and hemolytic anemia with phenazopyridine: possible relation to acute renal failure.Arch Intern Med. 1977 Nov;137(11):1636-8. Arch Intern Med. 1977. PMID: 921457
-
Methemoglobinemia, muscle damage and renal failure complicating phenazopyridine overdose.Isr J Med Sci. 1986 Jan;22(1):45-7. Isr J Med Sci. 1986. PMID: 3957643
-
Methemoglobinemia and hemolytic anemia after phenazopyridine hydrochloride (Pyridium) administration in end-stage renal disease.South Med J. 1989 Mar;82(3):372-4. doi: 10.1097/00007611-198903000-00023. South Med J. 1989. PMID: 2922627
-
Phenazopyridine hydrochloride toxicity: a cause of drug-induced methemoglobinemia.JACEP. 1979 Oct;8(10):426-31. doi: 10.1016/s0361-1124(79)80409-8. JACEP. 1979. PMID: 385954 Review. No abstract available.
-
Phenazopyridine associated acute interstitial nephritis and review of literature.Ren Fail. 2014 Jun;36(5):804-7. doi: 10.3109/0886022X.2014.890054. Epub 2014 Feb 27. Ren Fail. 2014. PMID: 24575779 Review.